Patient Guide: A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 39 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06767800
Status: 🟢 Enrolling Now
Condition: Gastroesophageal Adenocarcinoma
Phase: PHASE2

Where You Can Participate

This study is available at 39 locations across the country.

Top locations include:
  • • Fuyang, Anhui
  • • Lu'an, Anhui
  • • Maanshan, Anhui
  • • And 36 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma - Join Clinical Trial NCTNCT06767800

How to Join This Clinical Trial - NCTNCT06767800

Learn how to participate in this PHASE2 trial studying an investigational therapy for Gastroesophageal Adenocarcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Gastroesophageal Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Gastroesophageal Adenocarcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06767800 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 39 locations. Find a study site near you:

Clinical Research Site

Fuyang, Anhui 23600 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Lu'an, Anhui 237000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Maanshan, Anhui 243000 - China

Status: RECRUITING

Clinical Research Site

Beijing, Beijing 100730 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Chongqing, Chongqing 400016 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Fuzhou, Fujian 350014 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Lanzhou, Gansu 730000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Wuwei, Gansu 733099 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510060 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510515 - China

Status: NOT_YET_RECRUITING

And 29 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Gastroesophageal Adenocarcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships